TY - JOUR
T1 - Coronavirus Disease 2019 Messenger RNA Vaccines Associated With Delayed Onset of Breakthrough Infections and Fewer Radiographic Abnormalities
AU - Li, Xin
AU - Chan, Jacky Man Chun
AU - Lam, Bosco
AU - Lung, David Christopher
AU - Lung, Kwok Cheung
AU - Chow, Christina Kin Yi
AU - Tam, Tracey
AU - Chiu, Kelvin Hei Yeung
AU - Hung, Ling Lung
AU - Hung, Ivan Fan Ngai
AU - Cheng, Vincent Chi Chung
AU - To, Kelvin Kai Wang
AU - Yuen, Kwok Yung
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - This retrospective study of incoming travelers with coronavirus disease 2019 showed that individuals immunized by messenger RNA vaccines had significantly longer postvaccination intervals (median, 30.5 days) to breakthrough infection, lower white blood cell counts and lactate dehydrogenase levels on admission, and fewer radiographic abnormalities than those immunized by inactivated virus vaccine, who paradoxically had lower respiratory viral load.
AB - This retrospective study of incoming travelers with coronavirus disease 2019 showed that individuals immunized by messenger RNA vaccines had significantly longer postvaccination intervals (median, 30.5 days) to breakthrough infection, lower white blood cell counts and lactate dehydrogenase levels on admission, and fewer radiographic abnormalities than those immunized by inactivated virus vaccine, who paradoxically had lower respiratory viral load.
KW - COVID-19
KW - inactivated whole-virus vaccine
KW - mRNA vaccine
KW - vaccine breakthrough infection
UR - http://www.scopus.com/inward/record.url?scp=85131410139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131410139&partnerID=8YFLogxK
U2 - 10.1093/cid/ciab1062
DO - 10.1093/cid/ciab1062
M3 - Article
C2 - 34984442
AN - SCOPUS:85131410139
SN - 1058-4838
VL - 75
SP - E905-E908
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 1
ER -